Skip to main content

Infinity Pharmaceuticals, Inc.

INFIDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001113148

Infinity Pharmaceuticals, Inc. was delisted in 2023; its insiders filed their last Form 4 on Sep 12, 2023; 45 institutions reported holding it in 13F filings for Q2 2023, worth $4.23M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
45
Q2 2023, −8 vs. previous quarter
13F value
$4.23M
Reported value at the end of Q2 2023
Superinvestors holding
0
At the end of Q2 2023

Superinvestors holding INFI, Q2 2023

Go to the superinvestors tab

No superinvestor reported holding INFI at the end of Q2 2023.

Latest insider trades

Open-market purchases and sales by Infinity Pharmaceuticals, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 12, 2023 (view filing)6:20 PM ETSep 12Same dayPerkins Adelene QDirectorSSale−410.2K$0.07−$28.7K−25.9%1.18M after10b5-1
Aug 4, 2022 (view filing)Aug 22 daysPeluso StephaneChief Scientific OfficerSSale+15.0K$0.66+$9.90K+68.0%37.1K after

Top 10 13F holders, Q2 2023

The largest institutional positions in Infinity Pharmaceuticals, Inc. at the end of Q2 2023; share changes are against Q1 2023.

See all 45 holders
Institutions holding INFI in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc6,353,645$1.34M0.04%00.0%Unchanged
Vanguard Group Inc3,981,857$838.2K0.00%−13,017−0.3%Reduced
Sphera Funds Management Ltd.1,476,000$310.7K0.07%00.0%Unchanged
BlackRock Inc.1,461,881$307.7K0.00%+3520.0%Added
Carlson Capital L P1,300,000$273.6K0.02%+300,000+30.0%Added
Mariner, LLC1,195,000$252.0K0.00%+1,195,000New
Geode Capital Management, LLC807,517$170.0K0.00%00.0%Unchanged
Ergoteles LLC696,506$146.6K0.01%00.0%Unchanged
Renaissance Technologies LLC358,200$75.0K0.00%+123,200+52.4%Added
State Street Corp334,360$70.4K0.00%−7,700−2.3%Reduced